Jose' E. Cavazos
San Antonio, Texas, 78229, United States
NCT Number: NCT02555410
This is a phase III, pilot, prospective study of an Electromyography (EMG) based seizure detection system for detecting Generalized Tonic-Clonic Seizures (GTCS) in the home.
Looking for future studies?
Notify Me2 year–99 year
All sexes
Observational
San Antonio, Texas, 78229, United States
The Brain Sentinel™ Seizure Detection and Warning System is intended for monitoring children and adults with a history or significant risk of generalized tonic-clonic seizures in the home or healthcare facilities, during the titration or withdrawal of anti-epileptic drugs, and for continuous monitoring (night time or any other time of day) of individuals due to their history or risk of generalized tonic-clonic seizures. The device will withstand activities of daily living including showers and sleep.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A sEMG based automated seizure detection and warning system worn on the biceps
Other names: SPEAC System
Time frame: up to 1 month
The overall usability and technical features will be assessed through questionnaires and surveys as the Seizure Detection and Warning System will be used within a home setting.
Time frame: up to one month
Comparison of the subject's seizure diary to the EMG based seizure detection system's seizure logs will help determine overall function.
Brain Sentinel
Other
A Pivotal, Phase II Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01228747
Brain Diseases, Central Nervous System Diseases
Beijing, China
View Trial DetailsNCT02371200
Brain Diseases, Central Nervous System Diseases
Charleston, South Carolina, United States
View Trial DetailsNCT01398956
Brain Diseases, Central Nervous System Diseases
Fujisawa, Japan
View Trial DetailsNCT01292837
Brain Diseases, Central Nervous System Diseases
Akita, Japan
View Trial Details